Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $19.8 Million - $24.1 Million
-75,500 Reduced 75.35%
24,700 $7.72 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $97.4 Million - $118 Million
-362,200 Reduced 78.33%
100,200 $28.5 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $118 Million - $133 Million
462,400 New
462,400 $133 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $56.4 Million - $68.8 Million
250,000 New
250,000 $60.4 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $8.85 Million - $10.3 Million
-39,900 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $8.63 Million - $10.3 Million
39,900 New
39,900 $9.17 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $3.5 Million - $3.89 Million
-14,900 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $9.71 Million - $11.9 Million
-49,100 Reduced 76.72%
14,900 $213,000
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $7.38 Million - $9.79 Million
40,500 Added 172.34%
64,000 $13 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $4.09 Million - $4.9 Million
23,500 New
23,500 $4.55 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $6.67 Million - $7.82 Million
-40,000 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $36,174 - $40,776
-200 Reduced 0.5%
40,000 $7.6 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $5.39 Million - $6.29 Million
30,200 Added 302.0%
40,200 $7.83 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $30.1 Million - $33.8 Million
-181,100 Reduced 94.77%
10,000 $1.85 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $1.27 Million - $1.49 Million
-7,500 Reduced 3.78%
191,100 $32.6 Million
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $12.3 Million - $13.8 Million
-73,000 Reduced 26.88%
198,600 $34.5 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $45.4 Million - $51.9 Million
271,600
271,600 $50.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.